{
  "abstract": "Background CD8+ T cells differentiate into terminally exhausted T cells, a hypofunctional state induced in tumor environments that leads to impaired antitumor immunity and poor cancer prognosis. Therapeutic approaches to improve effector CD8+ T-cell function by limiting or reversing tumor-mediated exhaustion are areas of active investigation. Terminally exhausted CD8+ T cells from tumors exhibit increased transcriptional repression of effector genes by tri-methylation of histone 3 lysine 27 (H3K27me3). Enhancer of zeste homolog 2 (Ezh2) is a crucial enzyme acting as the catalytic core of the polycomb repressive complex 2, which adds H3K27me3 in T cells.Methods Using pharmacologic and genetic suppression of Ezh2, we evaluated its role in driving CD8+ T-cell exhaustion in vitro and in murine melanoma models in vivo, including its impact on functional restoration.Results Ezh2 expression is significantly increased in CD8+ T cells exposed to chronic stimulation. Suppression of Ezh2 significantly increased the proportion of CD8+ T cells expressing both tumor necrosis factor and interferon-γ when exposed to chronic stimulation in vitro or in the tumor. Ezh2-deficient CD8+ T cells also exhibited decreases in the exhaustion-mediated transcription factor Tox. Multiple genes were upregulated when Ezh2 was deleted, including cytokines related to type 1 (eg, Gzmc) and type 2 (eg, Il13) immunity, and treatment with interleukin (IL)-4 induced a significantly higher proportion of IL-13-expressing CD8+ T cells.Conclusions These findings suggest that Ezh2 contributes to epigenetic modifications supporting T-cell exhaustion, and Ezh2 suppression or deletion can rescue effector functions of exhausted CD8+ T cells. Thus, Ezh2 may be a therapeutic target to improve antitumor immunity.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA",
    "1University of Pittsburgh, Pittsburgh, USA",
    "University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA",
    "Department of Pediatrics, Division of Pediatric Rheumatology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA",
    "Center for Systems Immunology, Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 8,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Greg M Delgoffe"
    },
    {
      "affs": [
        1
      ],
      "name": "Hannah Bumgarner"
    },
    {
      "affs": [
        2
      ],
      "name": "Catherine Yang"
    },
    {
      "affs": [
        3
      ],
      "name": "Aaron Yang"
    },
    {
      "affs": [
        3
      ],
      "name": "Amanda C Poholek"
    },
    {
      "affs": [
        4
      ],
      "name": "Xingjian Qiu"
    },
    {
      "affs": [
        4
      ],
      "name": "B Rhodes Ford"
    },
    {
      "affs": [
        4
      ],
      "name": "Shilpi Giri"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/4hvcppw86krey.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-016004",
  "fulltext_url": "https://jitc.bmj.com/content/14/11/e016004.full",
  "id": "4hvcppw86krey",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-016004",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ]
  ],
  "openalex": null,
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-16",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/4hvcppw86krey.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T15:21:14Z",
      "native_id": "0e7e4dd65f1d49ba88cede157325af09",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-016004"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "journal-openalex:2403|Immunotherapy and Immune Responses",
      "subfield": "immunology"
    },
    {
      "field": "medicine",
      "origin": "lcc:RC254-282",
      "subfield": "oncology"
    }
  ],
  "title": "Ezh2 represses effector genes that contribute to the development of tumor-mediated CD8+ T-cell exhaustion",
  "title_text": "Ezh2 represses effector genes that contribute to the development of tumor-mediated CD8+ T-cell exhaustion",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T15:21:14Z",
  "url": "https://research.draconitic.com/paper/4hvcppw86krey",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}